Literature DB >> 10230838

Redundancy of single diagnostic test evaluation.

K G Moons1, G A van Es, B C Michel, H R Büller, J D Habbema, D E Grobbee.   

Abstract

Diagnostic research and diagnostic practice frequently do not cohere. Studies commonly evaluate whether a single test discriminates between disease presence and absence, whereas in practice a test is always judged in the context of other information. This study illustrates drawbacks of single-test evaluation and discusses principles of diagnostic research. We used data on 140 patients suspected of pulmonary embolism who had an inconclusive ventilation-perfusion lung scan. We evaluated three tests: partial pressure of oxygen in arterial blood (PaO2), x-ray film of the thorax, and leg ultrasound. On the basis of single-test evaluations, ultrasound was most informative. Given a prior probability of 0.27, it had a much better combination of positive and negative predictive value (0.71 and 0.21, respectively) relative to thorax x-ray (0.33 and 0.11) and PaO2 (0.35 and 0.27). The combination of positive and negative likelihood ratio was also more promising for ultrasound (7.3 and 0.7) than for thorax x-ray (1.3 and 0.3) and PaO2 (1.3 and 0.9). As the tests are always performed after the history and physical, we judged their added value using multivariable logistic modeling with receiver operating characteristic (ROC) analyses. The ROC areas of the model, including history and physical, with additional PaO2, thorax x-ray, or ultrasound, were 0.75, 0.77, 0.81, and 0.81, respectively, which indicated similar added value of thorax x-ray and ultrasound. Application of the models to patient subgroups also yielded added predictive value for thorax x-ray film. Thus, the results of single-test evaluations may be very misleading. As no diagnosis is based on one test, single-test evaluations have limited value in diagnostic research and only have relevance in the context of screening and the initial phase of test development. Diagnostic research should always apply an approach of constructing, extending, and validating diagnostic models in agreement with routine clinical work-up using logistic regression analyses.

Entities:  

Mesh:

Year:  1999        PMID: 10230838

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  10 in total

1.  Epidemiology in the right direction: the importance of descriptive research.

Authors:  Diederick E Grobbee
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Evidence based diagnosis: multiple tests with multiple responses are important.

Authors:  Ram Kumar
Journal:  BMJ       Date:  2006-09-09

3.  Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.

Authors:  Frans H Rutten; Karel G M Moons; Maarten-Jan M Cramer; Diederick E Grobbee; Nicolaas P A Zuithoff; Jan-Willem J Lammers; Arno W Hoes
Journal:  BMJ       Date:  2005-12-01

4.  Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT.

Authors:  Seung Ha Park; Chang Hoon Kim; Dong Joon Kim; Jae Youn Cheong; Sung Won Cho; Seong Gyu Hwang; Youn Jae Lee; Mong Cho; Jin Mo Yang; Young Bae Kim
Journal:  Dig Dis Sci       Date:  2010-11-18       Impact factor: 3.199

Review 5.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

6.  A diagnostic decision rule for management of children with meningeal signs.

Authors:  Rianne Oostenbrink; Karel G M Moons; Carl G M Moons; Arda G Derksen-Lubsen; Diederick E Grobbee; Henriette A Moll
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.

Authors:  M X Rangaka; H P Gideon; K A Wilkinson; M Pai; J Mwansa-Kambafwile; G Maartens; J R Glynn; A Boulle; K Fielding; R Goliath; R Titus; S Mathee; R J Wilkinson
Journal:  Eur Respir J       Date:  2011-06-30       Impact factor: 16.671

8.  A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.

Authors:  Caroline Elie; Joël Coste
Journal:  BMC Med Res Methodol       Date:  2008-02-21       Impact factor: 4.615

9.  Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).

Authors:  Alexander Kluttig; Pietro Trocchi; Anke Heinig; Hans-Juergen Holzhausen; Christiane Taege; Steffen Hauptmann; Werner Boecker; Thomas Decker; Thomas Loening; Andrea Schmidt-Pokrzywniak; Christoph Thomssen; Tilmann Lantzsch; Joerg Buchmann; Andreas Stang
Journal:  BMC Cancer       Date:  2007-06-14       Impact factor: 4.430

10.  A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard.

Authors:  Daphne I Ling; Madhukar Pai; Ian Schiller; Nandini Dendukuri
Journal:  BMC Med Res Methodol       Date:  2014-05-15       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.